AbbVie has consolidated its leading position in the field of migraine with positive phase III study results on the treatment of menstrual migraines with atogipam.

Zhitongcaijing · 2d ago
AbbVie has consolidated its leading position in the field of migraine with positive phase III study results on the treatment of menstrual migraines with atogipam.